Purchase Order 36C24626P0270

This is a firm-fixed-price delivery order awarded by the Defense Health Agency (DHA) to Olink Proteomics Inc., a foreign-owned, for-profit biotechnology company, for the provision of Olink Target 96 reagent kits. The contract has a ceiling value of $37,484.25 and a performance period ending on July 14, 2025. Olink Proteomics specializes in innovative protein biomarker discovery solutions for various research areas, including aging, cancer, neurodegenerative diseases, diabetes, and infectious...

The National Institutes of Health's National Human Genome Research Institute awarded a $697,695 firm fixed price purchase order to Olink Proteomics AB of Uppsala, Sweden. The one-year contract calls for Olink to measure the proteomic profiles of 1,000 plasma samples across 3,072 proteins using its proprietary Olink Explore 3072 technology. Performance will take place at Olink's facilities in Uppsala and Boston. There was no set-aside designation, as the sole-source award was made directly to...

This is a firm fixed-price purchase order awarded by the National Institute on Aging (NIA), a civilian agency within the National Institutes of Health (NIH), to Olink Proteomics Inc., a foreign-owned for-profit biotechnology company. The contract is for the procurement of Olink Explore HT Reagent Kits, specialized biological and reagent materials used in advanced proteomics research. The contract has a ceiling value of $24,961.31 and a period of performance through September 17, 2025. Olink...

This purchase order, valued at $77,330, was awarded by the National Institutes of Health's National Cancer Institute to Olink Proteomics Inc. to provide normalized expression data from multiplexed immunoassays using the Olink Explore 3072 platform. The services will support research conducted by the Pediatric Oncology Branch. As a sole source award under FAR Part 12, the contract calls for Olink to leverage its proprietary technology to deliver specialized proteomics analysis services to NIH/NCI...

The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Aging awarded a firm fixed-price purchase order contract to Olink Proteomics Inc., a foreign-owned for-profit biotechnology company, for an EXPLORE 3072 Reagent Kit. The contract has a potential value of $184,037.60 and a completion date of August 31, 2022. Olink Proteomics has been awarded numerous federal contracts from agencies such as NIH, FDA, and Department of Veterans Affairs to...

Olink Proteomics AB was awarded a $31,130 firm fixed price delivery order against an unspecified contract vehicle to provide OLINK 1536 analysis services in support of the National Cancer Institute's Pediatric Oncology Branch programs. The services will be performed in Waltham, Massachusetts with work expected to be completed by December 16, 2022. The award was made by the Department of Health and Human Services' National Institutes of Health National Cancer Institute on December 15, 2021...

This is a firm-fixed-price purchase order awarded by the National Institute on Aging (NIA), a civilian agency within the U.S. Department of Health and Human Services, to Olink Proteomics Inc., a foreign-owned, for-profit biotechnology company. The $98,392.48 contract is for the delivery of the Olink Explore 3072 Proteomics Screening Kit, which supports the agency's biomedical research missions in areas such as aging, cancer, and neurodegenerative diseases. Olink Proteomics has a significant...

The U.S. Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke awarded a $198,740.56 firm fixed price purchase order to Olink Proteomics Inc., a foreign-owned for-profit biotechnology company, for Olink Explore 3072 reagent kits. The contract is for the delivery of these reagents by September 6, 2023. Olink Proteomics has a history of providing various proteomics instruments, reagents, kits, analysis services,...

This is a firm fixed price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), part of the National Institutes of Health (NIH), to Olink Proteomics AB, a foreign-owned for-profit company based in Sweden. The $69,388 contract is for Olink to provide laboratory services, specifically protein biomarker analysis using their proprietary multiplex platforms, to support NICHD's biomedical research across disease areas such as cancer, cardiovascular disease,...

This is a firm fixed-price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health (NIH), to Olink Proteomics Inc., a foreign-owned for-profit biotechnology company. The contract, valued at $24,424.80, is for Olink to provide proteomics assays to support an NHLBI research project investigating the link between plasma myokine abundance and physical capacity in patients with non-tuberculous mycobacterial...